News
September 10, 2014, 04:48
Caraco Pharmaceutical Laboratories has received a warning letter from the FDA after the agency’s inspection of the company’s Detroit manufacturing plant. Caraco Pharmaceutical Laboratories, Ltd. Receives FDA Warning Letter . DETROIT Nov. 3 /PRNewswire-FirstCall/ -- On October 31, 2008, Caraco Pharmaceutical. U.S. Marshals, at the request of the Food and Drug Administration, today seized drug products manufactured by Caraco Pharmaceutical Laboratories Ltd. CERTIFIED MAIL RETURN RECEIPT REQUESTED. WARNING LETTER 2008-DT-05. October 31, 2008 . Daniel H. Movens Chief Executive Officer Caraco Pharmaceutical Laboratories, Ltd. US generic and private-label drugmaker Caraco Pharmaceutical Laboratories has received a warning letter. Caraco Pharmaceutical Laboratories, Ltd. announced today that it will be filing its response to the FDA warning letter on November 24, 2008 as planned. On October 31, 2008, Caraco Pharmaceutical Laboratories, Ltd. received a warning letter from the FDA. The letter was issued as a follow up to the last FDA inspe Caraco Pharmaceuticals has received a Food & Drug Administration (FDA) warning letter because of conditions at its Detroit, Michigan plant. The FDA is withholding. Caraco Pharmaceutical Laboratories, Ltd. (CPD) Receives FDA Warning Letter FDA Approves Johnson & Johnson (JNJ)'s Tapentadol Immediate-Release Tablets for Relief of. Caraco Pharmaceuticals has received a Food & Drug Administration (FDA) warning letter because of conditions at its Detroit, Michigan plant. The FDA is withholding all..
September 11, 2014, 07:25
September 13, 2014, 12:55
CERTIFIED MAIL RETURN RECEIPT REQUESTED. WARNING LETTER 2008-DT-05. October 31, 2008 . Daniel H. Movens Chief Executive Officer Caraco Pharmaceutical Laboratories, Ltd. Caraco Pharmaceutical Laboratories, Ltd. (CPD) Receives FDA Warning Letter FDA Approves Johnson & Johnson (JNJ)'s Tapentadol Immediate-Release Tablets for Relief of. U.S. Marshals, at the request of the Food and Drug Administration, today seized drug products manufactured by Caraco Pharmaceutical Laboratories Ltd. Caraco Pharmaceuticals has received a Food & Drug Administration (FDA) warning letter because of conditions at its Detroit, Michigan plant. The FDA is withholding all. On October 31, 2008, Caraco Pharmaceutical Laboratories, Ltd. received a warning letter from the FDA. The letter was issued as a follow up to the last FDA inspe Caraco Pharmaceutical Laboratories has received a warning letter from the FDA after the agency’s inspection of the company’s Detroit manufacturing plant. Caraco Pharmaceuticals has received a Food & Drug Administration (FDA) warning letter because of conditions at its Detroit, Michigan plant. The FDA is withholding. US generic and private-label drugmaker Caraco Pharmaceutical Laboratories has received a warning letter. Caraco Pharmaceutical Laboratories, Ltd. announced today that it will be filing its response to the FDA warning letter on November 24, 2008 as planned..
September 15, 2014, 14:26
September 16, 2014, 04:36
CERTIFIED MAIL RETURN RECEIPT REQUESTED. WARNING LETTER 2008-DT-05. October 31, 2008 . Daniel H. Movens Chief Executive Officer Caraco Pharmaceutical Laboratories, Ltd. Caraco Pharmaceutical Laboratories, Ltd. announced today that it will be filing its response to the FDA warning letter on November 24, 2008 as planned. U.S. Marshals, at the request of the Food and Drug Administration, today seized drug products manufactured by Caraco Pharmaceutical Laboratories Ltd. US generic and private-label drugmaker Caraco Pharmaceutical Laboratories has received a warning letter. Caraco Pharmaceuticals has received a Food & Drug Administration (FDA) warning letter because of conditions at its Detroit, Michigan plant. The FDA is withholding. Caraco Pharmaceutical Laboratories, Ltd. (CPD) Receives FDA Warning Letter FDA Approves Johnson & Johnson (JNJ)'s Tapentadol Immediate-Release Tablets for Relief of. Caraco Pharmaceutical Laboratories has received a warning letter from the FDA after the agency’s inspection of the company’s Detroit manufacturing plant. Caraco Pharmaceuticals has received a Food & Drug Administration (FDA) warning letter because of conditions at its Detroit, Michigan plant. The FDA is withholding all. Caraco Pharmaceutical Laboratories, Ltd. Receives FDA Warning Letter . DETROIT Nov. 3 /PRNewswire-FirstCall/ -- On October 31, 2008, Caraco Pharmaceutical. On October 31, 2008, Caraco Pharmaceutical Laboratories, Ltd. received a warning letter from the FDA. The letter was issued as a follow up to the last FDA inspe.
September 16, 2014, 21:18
Caraco Pharmaceutical Laboratories has received a warning letter from the FDA after the agency’s inspection of the company’s Detroit manufacturing plant. US generic and private-label drugmaker Caraco Pharmaceutical Laboratories has received a warning letter. U.S. Marshals, at the request of the Food and Drug Administration, today seized drug products manufactured by Caraco Pharmaceutical Laboratories Ltd. Caraco Pharmaceutical Laboratories, Ltd. announced today that it will be filing its response to the FDA warning letter on November 24, 2008 as planned. Caraco Pharmaceuticals has received a Food & Drug Administration (FDA) warning letter because of conditions at its Detroit, Michigan plant. The FDA is withholding. CERTIFIED MAIL RETURN RECEIPT REQUESTED. WARNING LETTER 2008-DT-05. October 31, 2008 . Daniel H. Movens Chief Executive Officer Caraco Pharmaceutical Laboratories, Ltd. Caraco Pharmaceuticals has received a Food & Drug Administration (FDA) warning letter because of conditions at its Detroit, Michigan plant. The FDA is withholding all. Caraco Pharmaceutical Laboratories, Ltd. (CPD) Receives FDA Warning Letter FDA Approves Johnson & Johnson (JNJ)'s Tapentadol Immediate-Release Tablets for Relief of. On October 31, 2008, Caraco Pharmaceutical Laboratories, Ltd. received a warning letter from the FDA. The letter was issued as a follow up to the last FDA inspe Caraco Pharmaceutical Laboratories, Ltd. Receives FDA Warning Letter . DETROIT Nov. 3 /PRNewswire-FirstCall/ -- On October 31, 2008, Caraco Pharmaceutical..
Read more news
Fda warning letter caraco
View more publications